Cory Foster
Family · Spartanburg, SCNPI 1083950935
Payments from drug & device makers
Across 295 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$799
- Pfizer$590
- Novo Nordisk$433
- AstraZeneca$425
- Lilly USA, LLC$281
- Dexcom, Inc.$279
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,764100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $799 |
| Pfizer | 38 | $590 |
| Novo Nordisk | 36 | $433 |
| AstraZeneca | 27 | $425 |
| Lilly USA, LLC | 17 | $281 |
| Dexcom, Inc. | 15 | $279 |
| Amgen | 15 | $223 |
| Bayer | 11 | $172 |
| Novartis | 9 | $164 |
| GSK | 8 | $141 |
| Johnson & Johnson | 7 | $127 |
| Boehringer Ingelheim | 6 | $118 |
| Exact Sciences | 5 | $82 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Verona Pharma, Inc. | 4 | $75 |
| Astellas Pharma US Inc | 4 | $73 |
| Merck | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Eisai Inc. | 2 | $52 |
| Esperion Therapeutics, Inc. | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Abiomed | 2 | $41 |
| Ascensia Diabetes Care US Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Radius Health, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Halozyme Inc | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$4,764 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $28,330 |
| FarxigaDapagliflozin Propanediol | 18 | $19,039 |
| LinzessLinaclotide | 27 | $16,421 |
| XareltoRivaroxaban | 20 | $13,798 |
| JardianceEmpagliflozin | 17 | $13,744 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $11,702 |
| EliquisApixaban | 16 | $9,513 |
| JanuviaSitagliptin Phosphate | 12 | $7,890 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $2,153 |
| Rosuvastatin Calcium | 94 | $1,413 |
| Atorvastatin Calcium | 135 | $1,337 |
| Gabapentin | 90 | $1,127 |
| Bupropion XlBupropion Hcl | 48 | $919 |
| Losartan Potassium | 83 | $803 |
| Duloxetine Hcl | 25 | $791 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $433 | $28,33023 claims |
| AstraZenecaFarxiga | $425 | $19,03918 claims |
| AbbVieLinzess | $799 | $16,42127 claims |
| Johnson & JohnsonXarelto | $127 | $13,79820 claims |
| Boehringer IngelheimJardiance | $118 | $13,74417 claims |
| GSKTrelegy Ellipta | $141 | $11,70212 claims |
| PfizerEliquis | $590 | $9,51316 claims |
| MerckJanuvia | $72 | $7,89012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Spartanburg
- Ashley McKinneySpartanburg$16K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.